Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome
Yıl: 2018 Cilt: 21 Sayı: 1 Sayfa Aralığı: 34 - 37 Metin Dili: İngilizce İndeks Tarihi: 31-01-2020
Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome
Öz: Avascular necrosis (AVN) is a well-known but rare complication in patients with systemiclupus erythematosus (SLE) and anti-phospholipid syndrome (APS), usually affecting weight-bearing bonesand is most common in the femoral head. AVN has been reported in 2-30% of patients with SLE. In thisarticle, I reported a 27-year-old man with a 6-year history of SLE, previously treated with high dose corticosteroidsand cyclophosphamide pulse therapy for lupus nephritis presented to our clinic complainingof severe chronic pain in his bilateral knee and left ankle. X-rays and magnetic resonance imaging of kneeand ankle revealed bone infarctions .We prescribed low-dose aspirin. The syndrome of multiple avasculernecrosis and bone infarcts is a rare cause of musculoskeletal pain in patients with SLE.
Anahtar Kelime: Konular:
Sistemik Lupus Eritematozus ve Anti-fosfolipit Sendromlu Bir Hastada Kemik İnfarktları
Öz: Avasküler nekroz (AVN), sistemik lupus eritematozus (SLE) ve anti-fosfolipit sendrom hastalarında iyi bilinen, ancak nadir bir komplikasyondur. Genellikle ağırlık taşıyan kemikler etkilenir ve femur başı tutulumu yaygındır. AVN, SLE hastalarının %2-30’u olarak bildirilmiştir. Bu makalede 6 yıllık SLE geçmişi olan 27 yaşındaki erkek hasta sunuldu. Daha önce lupus nefriti için yüksek doz kortikosteroid ve pulse siklofosfamid ile tedavi edilen hasta, her iki diz ve sol ayak bileğinde kronik ağrı şikâyetiyle kliniğimize başvurdu. X-ray ve diz, ayak bileği manyetik rezonans görüntüleme ile dizler ve el bileklerinde kemik infarktları saptandı. Düşük doz aspirin reçete edildi. Birden fazla avasküler nekroz ve kemik infarktları SLE hastalarında kas iskelet ağrısının nadir bir nedenidir.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- Asherson RA, Lioté F, Page B, et al. Avasculer necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol. 1993;20:284-8.
- Halland AM, Klemp P, Botes D, et al. Avasculer necrosis of the hip in systemic lupus erythematosus: the role of magnetic resonance imaging. Br J Rheumatol. 1993;32: 972-6.
- Mok MY, Farewell VT, Isenberg DA. Risk factors for avasculer necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? Ann Rheum Dis. 2000;59:462-7.
- Gontero RP, Bedoya ME, Benavente E, et al. Osteonecrosis in systemic lupus erythematosus. Reumatol Clin. 2015;11:151-5.
- Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677- 86.
- Uthman I, Noureldine M, Berjawi A, et al. Hughes syndrome and multiple sclerosis. Lupus. 2015;24:115-21.
- Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295- 306.
- Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol. 2003;25:13-24.
- Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006;73:500-7.
- Perez-Pampin E, Mera A, Campos J. Bone ınfarctions in a patient with systemic lupus erythematosus and anti-cardiolipin antibodies. J Clin Rheumatol. 2010;16:54.
- Rueda JC, Duque MA, Mantilla RD, et al. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol. 2009;15:130-2.
- Assouline-Dayan Y, Chang C, Greenspan A, et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32: 94-124.
- Gladman DD, Chaudhry-Ahluwalia V, Ibañez D, et al. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol. 2001;28:2226- 9.
- Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthiritis Rheum. 2003;48:732-6.
- Zonana-Nacach A, Jiménez-Balderas FJ. Avasculer necrosis of bone associated with primary antiphospholipid syndrome: case report and literature review. J Clin Rheumatol. 2004;10:214-7.
- Chatterjee S. Bone infarcts in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome. CMAJ. 2006;174: 455-6.
- Mont MA, Glueck CJ, Pacheco IH, et al. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997;24:654-62.
- Nagasawa K, Tada Y, Koarada S, et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus. 2005;14:385-90.
- Aranow C, Zelicof S, Leslie D, et al. Clinically occult avasculer necrosis of the hipin systemic lupus erythematosus. J Rheumatol. 1997;24: 2318-22.
- Péré P, Régent D, Vivard T, et al. Magnetic resonance imaging of bone infarction. Apropos of 2 cases. J Radiol. 1998;69:597-601.
APA | ORDAHAN B, karahan a (2018). Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. , 34 - 37. |
Chicago | ORDAHAN BANU,karahan ali yavuz Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. (2018): 34 - 37. |
MLA | ORDAHAN BANU,karahan ali yavuz Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. , 2018, ss.34 - 37. |
AMA | ORDAHAN B,karahan a Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. . 2018; 34 - 37. |
Vancouver | ORDAHAN B,karahan a Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. . 2018; 34 - 37. |
IEEE | ORDAHAN B,karahan a "Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome." , ss.34 - 37, 2018. |
ISNAD | ORDAHAN, BANU - karahan, ali yavuz. "Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome". (2018), 34-37. |
APA | ORDAHAN B, karahan a (2018). Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, 21(1), 34 - 37. |
Chicago | ORDAHAN BANU,karahan ali yavuz Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi 21, no.1 (2018): 34 - 37. |
MLA | ORDAHAN BANU,karahan ali yavuz Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, vol.21, no.1, 2018, ss.34 - 37. |
AMA | ORDAHAN B,karahan a Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi. 2018; 21(1): 34 - 37. |
Vancouver | ORDAHAN B,karahan a Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi. 2018; 21(1): 34 - 37. |
IEEE | ORDAHAN B,karahan a "Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome." Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, 21, ss.34 - 37, 2018. |
ISNAD | ORDAHAN, BANU - karahan, ali yavuz. "Bone Infarctions in a Patient with Systemic Lupus Erythematosus and Anti-phospholipid Syndrome". Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi 21/1 (2018), 34-37. |